Monte Rosa Therapeutics, Inc.
GLUE- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001826457
In the last 90 days, Monte Rosa Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 192 institutions reported holding it in 13F filings for Q2 2026, worth $2.24B in total; Duquesne Family Office is the only superinvestor holding it.
13F holders, Q2 2021
Institutional positions in Monte Rosa Therapeutics, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- +48 vs. Q1 2021
- Shares held
- 32.1M
- +32.1M vs. Q1 2021
- Total value
- $705.1M
- +$705.1M vs. Q1 2021
- New holders
- 48
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GLUE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 192 | $2.24B |
| Q1 2026 | 191 | $1.43B |
| Q4 2025 | 161 | $1.01B |
| Q3 2025 | 129 | $444.9M |
| Q2 2025 | 116 | $280.6M |
| Q1 2025 | 106 | $276.2M |
| Q4 2024 | 105 | $423.3M |
| Q3 2024 | 81 | $263.7M |
| Q2 2024 | 75 | $171.7M |
| Q1 2024 | 68 | $281.3M |
| Q4 2023 | 71 | $226.6M |
| Q3 2023 | 71 | $201.4M |
| Q2 2023 | 68 | $272.3M |
| Q1 2023 | 69 | $309.8M |
| Q4 2022 | 66 | $313.8M |
| Q3 2022 | 70 | $328.8M |
| Q2 2022 | 57 | $375.0M |
| Q1 2022 | 52 | $559.9M |
| Q4 2021 | 53 | $742.0M |
| Q3 2021 | 56 | $759.4M |
| Q2 2021 | 48 | $705.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Monte Rosa Therapeutics, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 400 | $9.00K | 0.00% | +400 | New |
| Legal & General Group Plc | 3,000 | $69.0K | 0.00% | +3,000 | New |
| Wellington Management Group LLP | 9,192 | $209.0K | 0.00% | +9,192 | New |
| Maven Securities LTD | 11,106 | $213.0K | 0.02% | +11,106 | New |
| Tudor Investment Corp Et Al | 10,000 | $227.0K | 0.00% | +10,000 | New |
| Point72 Hong Kong Ltd | 10,606 | $241.0K | 0.02% | +10,606 | New |
| Qube Research & Technologies Ltd | 13,100 | $297.0K | 0.00% | +13,100 | New |
| Ghisallo Capital Management LLC | 20,000 | $454.0K | 0.02% | +20,000 | New |
| Point72 Asset Management, L.P. | 25,000 | $568.0K | 0.00% | +25,000 | New |
| Squarepoint Ops LLC | 28,209 | $640.0K | 0.00% | +28,209 | New |
| Norges Bank | 30,000 | $681.0K | 0.00% | +30,000 | New |
| TD Asset Management Inc | 38,764 | $950.0K | 0.00% | +38,764 | New |
| Pinz Capital Management, LP | 43,700 | $992.0K | 0.30% | +43,700 | New |
| Hound Partners, LLC | 49,995 | $1.14M | 0.06% | +49,995 | New |
| Alyeska Investment Group, L.P. | 50,000 | $1.14M | 0.01% | +50,000 | New |
| Caas Capital Management LP | 50,000 | $1.14M | 0.06% | +50,000 | New |
| LMR Partners LLP | 58,500 | $1.33M | 0.02% | +58,500 | New |
| Soleus Capital Management, L.P. | 75,000 | $1.70M | 0.26% | +75,000 | New |
| Citadel Advisors LLC | 95,792 | $2.17M | 0.00% | +95,792 | New |
| Vanguard Group Inc | 100,000 | $2.27M | 0.00% | +100,000 | New |
| HealthCor Management, L.P. | 100,000 | $2.27M | 0.09% | +100,000 | New |
| Sphera Funds Management Ltd. | 100,000 | $2.27M | 0.22% | +100,000 | New |
| Pura Vida Investments, LLC | 100,000 | $2.27M | 0.16% | +100,000 | New |
| Voya Investment Management LLC | 104,177 | $2.36M | 0.00% | +104,177 | New |
| Goldman Sachs Group Inc | 108,500 | $2.46M | 0.00% | +108,500 | New |
| Ratan Capital Management LP | 120,000 | $2.72M | 0.24% | +120,000 | New |
| Monashee Investment Management LLC | 120,000 | $2.72M | 0.33% | +120,000 | New |
| Sectoral Asset Management Inc | 129,633 | $2.94M | 0.24% | +129,633 | New |
| Alliancebernstein L.P. | 139,095 | $3.16M | 0.00% | +139,095 | New |
| Suvretta Capital Management, LLC | 150,000 | $3.40M | 0.05% | +150,000 | New |
| Woodline Partners LP | 208,068 | $4.72M | 0.09% | +208,068 | New |
| Millennium Management LLC | 235,102 | $5.34M | 0.01% | +235,102 | New |
| Octagon Capital Advisors LP | 238,045 | $5.40M | 1.12% | +238,045 | New |
| Jennison Associates LLC | 300,000 | $6.81M | 0.00% | +300,000 | New |
| Avidity Partners Management LP | 300,000 | $6.81M | 0.18% | +300,000 | New |
| Logos Global Management LP | 300,000 | $6.81M | 0.58% | +300,000 | New |
| Deerfield Management Company, L.P. (Series C) | 350,000 | $7.95M | 0.14% | +350,000 | New |
| OrbiMed Advisors LLC | 350,000 | $7.95M | 0.08% | +350,000 | New |
| Casdin Capital, LLC | 960,883 | $21.8M | 0.55% | +960,883 | New |
| RTW Investments, LP | 1,214,572 | $25.2M | 0.38% | +1,214,572 | New |
| Alphabet Inc. | 1,464,015 | $33.2M | 0.68% | +1,464,015 | New |
| Aisling Capital Management LP | 1,472,331 | $33.4M | 5.35% | +1,472,331 | New |
| BlackRock Inc. | 1,549,885 | $35.2M | 0.00% | +1,549,885 | New |
| Price T Rowe Associates Inc | 2,737,654 | $61.3M | 0.01% | +2,737,654 | New |
| Avoro Capital Advisors LLC | 3,311,434 | $62.2M | 1.08% | +3,311,434 | New |
| Cormorant Asset Management, LP | 3,193,973 | $69.5M | 2.71% | +3,193,973 | New |
| FMR LLC | 4,312,259 | $93.5M | 0.01% | +4,312,259 | New |
| NEA Management Company, LLC | 7,703,205 | $174.9M | 2.28% | +7,703,205 | New |